Triodos Investment Management BV Has $2.16 Million Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Triodos Investment Management BV grew its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 29.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 93,000 shares of the company's stock after buying an additional 21,000 shares during the quarter. Triodos Investment Management BV owned 0.38% of OrthoPediatrics worth $2,156,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Wellington Management Group LLP grew its holdings in OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company's stock worth $23,944,000 after acquiring an additional 122,846 shares in the last quarter. State Street Corp increased its holdings in OrthoPediatrics by 1.0% in the third quarter. State Street Corp now owns 417,898 shares of the company's stock valued at $11,329,000 after buying an additional 4,236 shares during the last quarter. Geode Capital Management LLC raised its stake in OrthoPediatrics by 2.1% during the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company's stock valued at $10,615,000 after buying an additional 7,972 shares in the last quarter. Portolan Capital Management LLC grew its position in shares of OrthoPediatrics by 66.2% in the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company's stock worth $8,353,000 after acquiring an additional 122,770 shares in the last quarter. Finally, Harbor Capital Advisors Inc. grew its position in shares of OrthoPediatrics by 1.9% in the 4th quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company's stock worth $5,832,000 after acquiring an additional 4,728 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.

Remove Ads

OrthoPediatrics Stock Up 0.1 %

Shares of OrthoPediatrics stock traded up $0.02 on Tuesday, hitting $24.65. 54,753 shares of the company traded hands, compared to its average volume of 198,227. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99. The company has a 50-day moving average price of $24.70 and a 200 day moving average price of $25.16. The company has a market cap of $598.67 million, a PE ratio of -20.04 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. The business had revenue of $52.67 million during the quarter, compared to analysts' expectations of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same quarter in the previous year, the business posted ($0.23) EPS. Sell-side analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Insider Activity

In other news, CFO Fred Hite sold 6,443 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $160,172.98. Following the completion of the sale, the chief financial officer now directly owns 207,989 shares in the company, valued at approximately $5,170,606.54. The trade was a 3.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David R. Bailey sold 6,620 shares of the firm's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the completion of the transaction, the chief executive officer now owns 319,155 shares in the company, valued at $7,934,193.30. The trade was a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,732 shares of company stock worth $589,978. 31.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on KIDS. Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a report on Wednesday, March 5th. Truist Financial reduced their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a research report on Wednesday, December 18th. Finally, Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.